Advertisement
| antiretroviral therapy for non-pregnant patients is: Reducing the Odds National Research Council, Board on Children, Youth, and Families, Institute of Medicine, Committee on Perinatal Transmission of HIV, 1999-02-13 Thousands of HIV-positive women give birth every year. Further, because many pregnant women are not tested for HIV and therefore do not receive treatment, the number of children born with HIV is still unacceptably high. What can we do to eliminate this tragic and costly inheritance? In response to a congressional request, this book evaluates the extent to which state efforts have been effective in reducing the perinatal transmission of HIV. The committee recommends that testing HIV be a routine part of prenatal care, and that health care providers notify women that HIV testing is part of the usual array of prenatal tests and that they have an opportunity to refuse the HIV test. This approach could help both reduce the number of pediatric AIDS cases and improve treatment for mothers with AIDS. Reducing the Odds will be of special interest to federal, state, and local health policymakers, prenatal care providers, maternal and child health specialists, public health practitioners, and advocates for HIV/AIDS patients. January |
| antiretroviral therapy for non-pregnant patients is: Nutrition and HIV Saurabh Mehta, Julia Finkelstein, 2018-05-15 The world continues to lose more than a million lives each year to the HIV epidemic, and nearly two million individuals were infected with HIV in 2017 alone. The new Sustainable Development Goals, adopted by countries of the United Nations in September 2015, include a commitment to end the AIDS epidemic by 2030. Considerable emphasis on prevention of new infections and treatment of those living with HIV will be needed to make this goal achievable. With nearly 37 million people now living with HIV, it is a communicable disease that behaves like a noncommunicable disease. Nutritional management is integral to comprehensive HIV care and treatment. Improved nutritional status and weight gain can increase recovery and strength of individuals living with HIV/AIDS, improve dietary diversity and caloric intake, and improve quality of life. This book highlights evidence-based research linking nutrition and HIV and identifies research gaps to inform the development of guidelines and policies for the United Nations’ Sustainable Development Goals. A comprehensive approach that includes nutritional interventions is likely to maximize the benefit of antiretroviral therapy in preventing HIV disease progression and other adverse outcomes in HIV-infected men and women. Modification of nutritional status has been shown to enhance the quality of life of those suffering HIV/AIDS, both physically in terms of improved body mass index and immunological markers, and psychologically, by improving symptoms of depression. While the primary focus for those infected should remain on antiretroviral treatment and increasing its availability and coverage, improvement of nutritional status plays a complementary role in the management of HIV infection. |
| antiretroviral therapy for non-pregnant patients is: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection World Health Organization, 2016 These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly. |
| antiretroviral therapy for non-pregnant patients is: Disease Control Priorities, Third Edition (Volume 6) King K. Holmes, Stefano Bertozzi, Barry R. Bloom, Prabhat Jha, 2017-11-06 Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings. |
| antiretroviral therapy for non-pregnant patients is: Counselling for Maternal and Newborn Health Care World Health Organization, 2010 The main aim of this practical Handbookis to strengthen counselling and communication skills of skilled attendants (SAs) and other health providers, helping them to effectively discuss with women, families and communities the key issues surrounding pregnancy, childbirth, postpartum, postnatal and post-abortion care. Counselling for Maternal and Newborn Health Careis divided into three main sections. Part 1 is an introduction which describes the aims and objectives and the general layout of the Handbook. Part 2 describes the counselling process and outlines the six key steps to effective counselling. It explores the counselling context and factors that influence this context including the socio-economic, gender, and cultural environment. A series of guiding principles is introduced and specific counselling skills are outlined. Part 3 focuses on different maternal and newborn health topics, including general care in the home during pregnancy; birth and emergency planning; danger signs in pregnancy; post-abortion care; support during labor; postnatal care of the mother and newborn; family planning counselling; breastfeeding; women with HIV/AIDS; death and bereavement; women and violence; linking with the community. Each Session contains specific aims and objectives, clearly outlining the skills that will be developed and corresponding learning outcomes. Practical activities have been designed to encourage reflection, provoke discussions, build skills and ensure the local relevance of information. There is a review at the end of each session to ensure the SAs have understood the key points before they progress to subsequent sessions. |
| antiretroviral therapy for non-pregnant patients is: A Guide to the Clinical Care of Women with HIV Jean R. Anderson, 2005 NOTE: NO FURTHER DISCOUNT FOR THIS PRODUCT ITEM -OVERSRTOCK SALE-- Significantly reduced price. Edited by Jean R. Anderson. This guide addresses the health care needs unique to women with HIV. It targets clinicians who provide primary care to women as well as those seeking an understanding of how to take care of women with HIV/AIDS. This guide includes tables, figures, color plates, resources, references, and indices. This 2005 edition includes new chapters on international issues and nutrition. Edge indexed. |
| antiretroviral therapy for non-pregnant patients is: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children , 2007 |
| antiretroviral therapy for non-pregnant patients is: Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2000 Evaluates the carcinogenic risks to humans posed by the use of four antiretroviral agents four DNA topoisomerase II inhibitors used in the treatment of cancer and an additional three pharmaceutical agents (hydroxyures phenolphthalein and vitamin K substances). The volume marks the first IARC evaluation of nucleoside analogs that act as antiviral agents. The evaluation responds in part to recent findings that zidovudine (AZT) an effective antiretroviral agent now being given to pregnant HIV-infected women to prevent maternal-to-fetal transmission of the virus is a transplacental carcinogen in mice. The opening monograph evaluates the carcinogenicity to humans of the antiretroviral nucleoside analogs zidovudine (AZT) zalcitabine (ddC) and didanosine (ddI) and the antiherpesvirus drug aciclovir. Of these aciclovir and didanosine could not be classified on the basis of available data. For zidovudine transplacental administration to mice resulted in an increased incidence and multiplicity of lung and liver tumours and in an increased incidence of female reproductive tract tumours in one study but not in another involving treatment at a lower dose. Despite observation of toxic effects in some studies of humans human carcinogenicity data were judged to provide inadequate evidence of carcinogenicity in humans. Zidovudine was classified as possibly carcinogenic to humans. Similar weaknesses in human carcinogenicity data for zalcitabine which consistently induces thymic lymphomas in mice resulted in its classification as possibly carcinogenic to humans. The second monograph evaluates four DNA topoisomerase II inhibitors: etoposide teniposide mitoxantrone and amsacrine. Of these etoposide - one of the most widely used and effective cytotoxic drugs in combination therapy - was classified as probably carcinogenic to humans and etoposide in combination with cisplatin and bleomycin was judged to be carcinogenic to humans. Teniposide was classified as probably carcinogenic to humans and mitoxantrone and amsacrine were classified as possibly carcinogenic to humans. Of the three pharmaceutical agents evaluated in the final monograph hydroxyurea which is widely used in cancer treatment and increasingly in combination with didanosine in HIV infection could not be classified. Phenolphthalein a widely used laxative now being withdrawn from the market in many countries because of toxicological concerns was classified as possibly carcinogenic. Vitamin K substances could not be classified on the basis of available evidence. |
| antiretroviral therapy for non-pregnant patients is: FDA's Drug Review Process and the Package Label Tom Brody, 2017-12-01 FDA's Drug Review Process and the Package Label provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, Clinical Study Reports, and Investigator's Brochures. The book provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug. In detail, the book reproduces data on efficacy and safety from one hundred different FDA-submissions (NDAs, BLAs). The book reproduces comments and complaints from FDA reviewers regarding data that are fragmentary, ambiguous, or that detract from the drug's approvability, and the book reveals how sponsors overcame FDA's concerns and how sponsors succeeded in persuading FDA to grant approval of the drug. The book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely text and data from NDAs and BLAs, as published on FDA's website. The source material for writing this book included about 80,000 pages from FDA's Medical Reviews, FDA's Clinical Pharmacology Reviews, and FDA's Pharmacology Reviews, from one hundred different NDAs or BLAs for one hundred different drugs. Each chapter focuses on a different section of the package label, e.g., the Dosage and Administration section or the Drug Interactions section, and demonstrates how the sponsor's data supported that section of the package label. - Reveals strategies for winning FDA approval and for drafting the package label - Examples are from one hundred FDA-submissions (NDAs, BLAs) for one hundred different drugs, e.g., for oncology, metabolic diseases, autoimmune diseases, and neurological diseases - This book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely, the data from NDAs and BLAs as published on FDA's website at the time FDA grants approval to the drug |
| antiretroviral therapy for non-pregnant patients is: Harrisons Manual of Medicine, 20th Edition Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo, 2019-10-22 All the authority of the most trusted brand in medical content in a convenient, portable guide A Doody's Core Titles for 2023! The Harrison’s Manual, derived from most clinically salient content featured in Harrison's Principles of Internal Medicine, 20th Edition, delivers numerous clinical algorithms in one practical, portable resource. The Manual also includes abundant quick reference tables, plus concise text—providing rapid access to bedside information when decisions need to be made quickly. This full color summary guide covers all diseases and conditions commonly seen in inpatient general medicine, so you can be sure to find invaluable content directly to your workflow and practice. The 20th edition has been updated to reflect the latest clinical developments in medicine. The Manual truly makes it easy to find what you need at the point of care. The easy-to-navigate chapters cover symptoms/signs, medical emergencies, specific diseases, and care of the hospitalized patient, with a particular focus on: Etiology and Epidemiology Clinically Relevant Pathophysiology Signs and Symptoms Differential Diagnosis Physical and Laboratory Findings Therapeutics Practice Guidelines, and more |
| antiretroviral therapy for non-pregnant patients is: Perinatal AIDS , 1988 |
| antiretroviral therapy for non-pregnant patients is: CDC Yellow Book 2018: Health Information for International Travel Centers for Disease Control and Prevention CDC, 2017-04-17 THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad. |
| antiretroviral therapy for non-pregnant patients is: HIV/AIDS in Latin America and the Caribbean , 1995 |
| antiretroviral therapy for non-pregnant patients is: Mixed Methods in Health Sciences Research Leslie Curry, Marcella Nunez-Smith, 2014-09-30 Mixed Methods in Health Sciences Research: A Practical Primer, by Leslie Curry and Marcella Nunez-Smith, presents key theories, concepts, and approaches in an accessible way. Packed with illustrations from the health sciences literature, this ready-to-use guidebook shows readers how to design, conduct, review, and use mixed methods research findings. Helpful checklists, figures, tables, templates, and much more give readers examples that will elevate the quality of their research, facilitate communication about their methods, and improve efficiency over the course of their projects. Real-world examples and insights from mixed methods researchers provide unique perspectives on every aspect of mixed methods research. This book successfully pulls together foundational mixed methods principles, synthesizes the knowledge base in the field, and translates it for a health science researcher audience. “The content is highly applicable to real life research teams in the areas of clinical research, health services research, and implementation science, providing sound content and practical advice. The authors have synthesized and pull key concepts from a variety of sources to provide a concise resource.” —Linda M. Herrick, South Dakota State University “Everything from the references, to the topics, checklists, conceptual graphic representations, and organizers, interviews, and resources, all contribute to the content and aid with understanding and/or application. … It addresses specific MM research as it pertains to health sciences in a way that other texts just do not even attempt.” —Denise L. Winsor, University of Memphis “[This text is] a very pragmatic approach to mixed methods research; excellent resources, tables, and figures [are] provided, along with cases and examples of value to researchers and grant reviewers. Its relevance to practice, education, and research, as well as to potential policy implications, is a strong focus that would make this a valued textbook for any researcher!” ? —Karen Devereaux Melillo, University of Massachusetts Lowell “The text is cutting edge. It leads the way with its focus on team dynamics. [The authors] succeed in making the book relevant and practical. They also articulate a number of key insights in the area of mixed methods that rarely get addressed, such as teams and conflict. Great read with a lot of good, practical information for mixed methods researchers at all levels. The practical approach of this text makes it an innovative and valuable resource.” —John G. Schumacher, University of Maryland |
| antiretroviral therapy for non-pregnant patients is: Just Health Norman Daniels, 2007-10-22 In this book by the award-winning author of Just Healthcare, Norman Daniels develops a comprehensive theory of justice for health that answers three key questions: what is the special moral importance of health? When are health inequalities unjust? How can we meet health needs fairly when we cannot meet them all? Daniels' theory has implications for national and global health policy: can we meet health needs fairly in ageing societies? Or protect health in the workplace while respecting individual liberty? Or meet professional obligations and obligations of justice without conflict? When is an effort to reduce health disparities, or to set priorities in realising a human right to health, fair? What do richer, healthier societies owe poorer, sicker societies? Just Health: Meeting Health Needs Fairly explores the many ways that social justice is good for the health of populations in developed and developing countries. |
| antiretroviral therapy for non-pregnant patients is: Gender Dimensions of HIV Status Disclosure to Sexual Partners Suzanne Maman, World Health Organization, Amy Medley, World Health Organization. Department of Gender, Women and Health, 2003-05 This review paper synthesizes the current information available on HIV status disclosure in terms of rates barriers and outcomes of HIV status disclosure among HIV-infected individuals. Particular emphasis is placed on women's experiences with disclosure to sexual partners. The report also aims to identify major barriers and describe programmatic and policy strategies that have been adopted to address these barriers and support women through the disclosure process. |
| antiretroviral therapy for non-pregnant patients is: Guidelines on the Management of Latent Tuberculosis Infection WHO, World Health Organization, 2015-01-15 BACKGROUND: Latent tuberculosis infection (LTBI), defined as a state of persistent immune response to prior-acquired Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB, affects about one-third of the world's population. Approximately 10% of people with LTBI will develop active TB disease in their lifetime, with the majority developing it within the first five years after initial infection. Currently available treatments have an efficacy ranging from 60% to 90%. Systematic testing and treatment of LTBI in at-risk populations is a critical component of WHO's eight-point framework adapted from the End TB Strategy to target pre-elimination and, ultimately, elimination in low incidence countries. OVERVIEW: Recognizing the importance of expanding the response to LTBI, in 2014 WHO developed Guidelines on the Management of Latent Tuberculosis Infection. The guidelines are primarily targeted at high-income or upper middle-income countries with an estimated TB incidence rate of less than 100 per 100 000 population, because they are most likely to benefit from it due to their current TB epidemiology and resource availability. The overall objective of the guidelines is to provide public health approach guidance on evidence-based practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. Specific objectives include identifying and prioritizing at-risk population groups for targeted intervention of LTBI testing and treatment, including defining an algorithm, and recommending specific treatment options. The guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management based on available resources, epidemiology of TB including intensity of transmission, the health-care delivery system of the country, and other national and local determinants. |
| antiretroviral therapy for non-pregnant patients is: Pregnancy C. H. Rodeck, 2003 This issue forms part of a series of expert reviews on selected health topics in fields where significant new developments are occurring. It is an invaluable reference source and allows those working in other specialities and younger clinicians and scientists to update their knowledge in important and well-defined subject areas. |
| antiretroviral therapy for non-pregnant patients is: HIV-related TB. , 1993 |
| antiretroviral therapy for non-pregnant patients is: South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 , 2014 |
| antiretroviral therapy for non-pregnant patients is: Genital Infections and Infertility , 19?? |
| antiretroviral therapy for non-pregnant patients is: HIV/AIDS Treatment and Care Irina Eramova, Srdan Matic, Monique Munz, 2007 The WHO Regional Office for Europe has combined its 13 protocols on treatment of and care for people with HIV and AIDS in one volume. The protocols are the cornerstone of the strategic actions that WHO has taken as part of its contribution to achieving the goal of universal access to HIV/AIDS prevention, treatment, care and support services. The protocols were specifically developed for the entire WHO European Region. Together, they represent a comprehensive and evidence-based tool that offers health professionals clear and specific advice on diagnosing and managing a wide range of health issues related to HIV/AIDS for adults, adolescents and children, including antiretroviral treatment, the management of opportunistic infections, tuberculosis, hepatitis, injecting drug use, sexual and reproductive health, the prevention of mother-to-child HIV transmission, immunization, palliative care and post-exposure prophylaxis. [Ed.] |
| antiretroviral therapy for non-pregnant patients is: The Holy Bible , 2007 |
| antiretroviral therapy for non-pregnant patients is: Evaluation and Management of Early HIV Infection , 1994 |
| antiretroviral therapy for non-pregnant patients is: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases John E. Bennett, MD, MACP, Raphael Dolin, MD, Martin J. Blaser, MD, 2014-08-28 After thirty five years, Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th Edition is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. John E. Bennett and Raphael Dolin along with new editorial team member Dr. Martin Blaser have meticulously updated this latest edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th Edition helps you identify and treat whatever infectious disease you see. Get the answers to questions you have with more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than you'll find in any other infectious disease resource. Find the latest diagnoses and treatments for currently recognized and newly emerging infectious diseases, such as those caused by avian and swine influenza viruses. Put the latest knowledge to work in your practice with new or completely revised chapters on influenza (new pandemic strains); new Middle East respiratory syndrome (MERS) virus; probiotics; antibiotics for resistant bacteria; antifungal drugs; new antivirals for hepatitis B and C; Clostridium difficile treatment; sepsis; advances in HIV prevention and treatment; viral gastroenteritis; Lyme disease; Helicobacter pylori; malaria; infections in immunocompromised hosts; immunization (new vaccines and new recommendations); and microbiome. Benefit from fresh perspectives and global insights from an expanded team of international contributors. Find and grasp the information you need easily and rapidly with newly added chapter summaries. These bulleted templates include diagnosis, therapy, and prevention and are designed as a quick summary of the chapter and to enhance relevancy in search and retrieval on Expert Consult. Stay current on Expert Consult with a thorough and regularly scheduled update program that ensures access to new developments in the field, advances in therapy, and timely information. Access the information you need easily and rapidly with new succinct chapter summaries that include diagnosis, therapy, and prevention. Experience clinical scenarios with vivid clarity through a richly illustrated, full-color format that includes 1500 photographs for enhanced visual guidance. |
| antiretroviral therapy for non-pregnant patients is: HIV Essentials 2012 Paul E. Sax, Calvin J. Cohen, Daniel R. Kuritzkes, 2012 The World's Leading Experts Provide All The 'Essentials' Needed To Manage Patients In The Office, On The Ward, And In The ICU. Completely Revised And Updated, HIV Essentials 2012 Incorporates The Latest Clinical Guidelines Into A Step-By-Step Guide To The Diagnosis, Evaluation, Management, And Prevention Of HIV Infection And Its Complications. Topics Include: Opportunistic Infections And Other HIV Complications, Treatment Of HIV And Pregnancy, Antiretroviral Drug Summaries, Post-Exposure Prophylaxis, As Well As Commercially Available Dosage Forms For All Arvs. New To HIV Essentials 2012: • 2011 DHHS Guidelines • 2011 Pregnancy Guidelines • New Drugs: Edurant, Complera, Incivek, Victrelis, And More. |
| antiretroviral therapy for non-pregnant patients is: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book John E. Bennett, Raphael Dolin, Martin J. Blaser, 2019-08-08 For four decades, physicians and other healthcare providers have trusted Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases to provide expert guidance on the diagnosis and treatment of these complex disorders. The 9th Edition continues the tradition of excellence with newly expanded chapters, increased global coverage, and regular updates to keep you at the forefront of this vitally important field. Meticulously updated by Drs. John E. Bennett, Raphael Dolin, and Martin J. Blaser, this comprehensive, two-volume masterwork puts the latest information on challenging infectious diseases at your fingertips. - Provides more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than any other infectious disease resource. - Features an increased focus on antibiotic stewardship; new antivirals for influenza, cytomegalovirus, hepatitis C, hepatitis B., and immunizations; and new recommendations for vaccination against infection with pneumococci, papillomaviruses, hepatitis A, and pertussis. - Covers newly recognized enteroviruses causing paralysis (E-A71, E-D68); emerging viral infections such as Ebola, Zika, Marburg, SARS, and MERS; and important updates on prevention and treatment of C. difficile infection, including new tests that diagnose or falsely over-diagnose infectious diseases. - Offers fully revised content on bacterial pathogenesis, antibiotic use and toxicity, the human microbiome and its effects on health and disease, immunological mechanisms and immunodeficiency, and probiotics and alternative approaches to treatment of infectious diseases. - Discusses up-to-date topics such as use of the new PCR panels for diagnosis of meningitis, diarrhea and pneumonia; current management of infected orthopedic implant infections; newly recognized infections transmitted by black-legged ticks in the USA: Borrelia miyamotoi and Powassan virus; infectious complications of new drugs for cancer; new drugs for resistant bacteria and mycobacteria; new guidelines for diagnosis and therapy of HIV infections; and new vaccines against herpes zoster, influenza, meningococci. - PPID continues its tradition of including leading experts from a truly global community, including authors from Australia, Canada and countries in Europe, Asia, and South America. - Includes regular updates online for the life of the edition. - Features more than 1,500 high-quality, full-color photographs—with hundreds new to this edition. - Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices. |
| antiretroviral therapy for non-pregnant patients is: HIV Essentials 2014 Paul E. Sax, Calvin J. Cohen, Daniel R. Kuritzkes, 2014-07-30 The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. Completely revised and updated, HIV Essentials 2014 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs. |
| antiretroviral therapy for non-pregnant patients is: Infectious Diseases of the Female Genital Tract Richard L. Sweet, Ronald S. Gibbs, 2012-03-29 Thoroughly updated and now featuring more than 100 full-color illustrations, the Fifth Edition of this comprehensive reference provides current, complete diagnostic and therapeutic information on infectious diseases of the female genital tract. This edition includes new chapters on human papillomavirus and the new vaccines and on infection as a cause of neonatal brain damage. The book emphasizes an evidence-based approach to recommendations and presents current guidelines for treatment of sexually transmitted diseases. The presentation of material has been streamlined to produce a smaller, more user-friendly text, and the format has been modified to include additional algorithms and tables. A companion Website will offer the fully searchable text and an image bank. |
| antiretroviral therapy for non-pregnant patients is: Intrapartum Management Modules Betsy B. Kennedy, Donna Jean Ruth, Elizabeth Jean Martin, 2009 The revised Fourth Edition of this essential text contains 19 modules that guide the reader from assessment of the pregnant woman and her fetus, through labor and delivery, to postpartum evaluation and care. Each module is carefully developed to enhance self-paced learning and skills attainment, perfect for competence validation and orientation. This edition has new modules on cultural competence and OB Emergencies, including hemorrhage and Caesarian delivery on demand, and new content on legal accountability, maternal and newborn transport, electronic fetal monitoring, and domestic violence assessment. |
| antiretroviral therapy for non-pregnant patients is: Adherence to Antiretroviral Therapy among Perinatal Women in Guyana Debbie Vitalis, 2021-09-02 The book documents the history of the prevention-of-mother-to child transmission of HIV (PMTCT) program in Guyana, as well as the impact of HIV on pregnant and postpartum women’s adherence to antiretroviral therapy (ART). The book shows research work by reviewing the literature to investigate relevant adherence studies, presenting in-depth interviews on adherence perspectives of clinic patients and healthcare providers, and a cross-sectional descriptive study of pregnant women that investigated general adherence to pregnancy-related behaviours and ART, and the efficacy of a theoretical model (Health Belief Model) to understand and predict ART adherence within this group. Author discusses the factors affecting ART adherence among pregnant and postpartum women, since existing studies may not account for cultural and other local variations. The findings provide insight into the local situation, and will also inform policy and practice in Guyana, and the wider Caribbean Community (CARICOM). |
| antiretroviral therapy for non-pregnant patients is: Obstetrics and Gynecology: A Competency-Based Companion E-Book Michael Belden, 2010-07-15 Designed to teach you to think like a more experienced clinician, Obstetrics and Gynecology: A Competency-Based Companion, by Michael Belden, MD, places as much value on process as it does on content. This unique resource features a case-based organization that hones in on essential knowledge in obstetrics and gynecology. Its convenient pocket-sized format enables you to review the material on the go, and online access via Student Consult enhances your study of the material and exponentially boosts your reference power. Provides high-yield core information essential to rotations in a pocket-sized, portable format. Uses a color-coded system that places core information in a framework of the ACGME Core Competencies. Offers self-assessment activities throughout to promote retention and application of knowledge, including access on line to your own competency-based portfolio tools and competency-specific learning modules (Vertical Reads). Features ACGME Core Competencies enabling you to integrate evidence-based medicine, continual self-assessment, and cognizance of interpersonal skills into your daily routine. Includes features such as “Speaking Intelligently” and “Clinical Thinking” in each chapter to help you see the “big picture.” Presents “Teaching Visuals”—an interactive teaching device designed to reinforce visual concepts. Equips you to perform a more in-depth review of obstetric and gynecological topics with “Clinical Entities” that link to top references in the field. Includes access to Student Consult at www.studentconsult.com, where you'll find the complete text and illustrations of the book online, fully searchable • Integration Links to bonus content in other Student Consult titles • Self-Assessment Competency Log • Professors Pearls that provide cases with questions and annotated answers • Vertical Reads • and much more! |
| antiretroviral therapy for non-pregnant patients is: HIV Essentials 2013 Paul E. Sax, Calvin J. Cohen, Daniel R. Kuritzkes, 2013-05-15 The world's leading experts provide all the 'Essentials' needed to manage patients in the office, on the ward, and in the ICU. Completely revised and updated, HIV Essentials 2013 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs. Important Notice: The digital edition of this book is missing some of the images or content found in the physical edition |
| antiretroviral therapy for non-pregnant patients is: A Guide to the Clinical Care of Women with HIV Jean Anderson (Gynecologist), 2000 |
| antiretroviral therapy for non-pregnant patients is: Sande's HIV/AIDS Medicine Paul Volberding, Warner Greene, Joep M. A. Lange, Joel E. Gallant, Nelson Sewankambo, 2012-04-13 Access the latest information available in the challenging area of HIV/AIDS management with Sande's HIV/AIDS Medicine, 2nd Edition. Authored by a veritable who's who of current global experts in the field, this medical reference book will provide you with all the practical, indispensable guidance you'll need to offer your patients the best possible care. - Access reliable, up-to-the-minute guidance that addresses the realities of HIV/AIDS management in your geographical region, thanks to contributions from a global cast of renowned expert clinicians and researchers. - Locate the clinically actionable information you need quickly with an organization that mirrors the current state of the AIDS epidemic and the different needs of Western vs. developing-world patients and clinicians. - Diagnose AIDS manifestations confidently by comparing them to full-color clinical images. - Improve patient outcomes with the latest findings on the management of AIDS as a chronic illness. - Efficiently review essential data through numerous at-a-glance tables. - Get the most relevant information available on pediatric HIV and AIDS issues; anti-retroviral drugs, including integrase inhibitors; and the use of second- and third-line anti-retroviral drugs in resource-poor settings. - Stay current on the latest actionable information, such as using antiretroviral therapy in patients with tuberculosis and drug-resistant tuberculosis; antiretroviral therapy; immune reconstitution inflammatory syndromes (IRIS); and implementation of the HPV vaccine. |
| antiretroviral therapy for non-pregnant patients is: Fundamentals of HIV Medicine 2023 The American Academy of Hiv Medicine, 2023-10-24 The essential textbook for HIV care providers and pharmacists--updated for 2023! Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine 2023 offers practitioners immediate, indexed access to the most recent science, research, and guidelines related to all aspects of HIV care and prevention. Now updated to reflect the convergent knowledge at the intersection of two global pandemics, HIV and COVID-19, Fundamentals of HIV Medicine 2023 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, physician assistants, nurses, and other professionals working in the care of HIV patients. This revised edition features key clinical updates across classic domains of HIV medicine along with new understandings of injectable antiretroviral treatment and explorations into concepts of HIV latency for long-term viral remission. Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2023 is a must-have for health professionals across HIV care, treatment, and prevention. |
| antiretroviral therapy for non-pregnant patients is: Federal Register , 1997-07-07 |
| antiretroviral therapy for non-pregnant patients is: Advanced Respiratory Critical Care Martin Hughes, Roland Black, 2011-09-01 Respiratory disease is the most common reason for admission to intensive care, and advanced respiratory support is one of the most frequently used interventions in critically ill patients. A clear understanding of respiratory disease is the cornerstone of high quality intensive care. Although a plethora of literature is available, both in print and online, finding the necessary relevant information can be difficult and time consuming. This handbook provides comprehensive clinical detail in an easily readable format. It is written by practising clinicians and has both in-depth theoretical discussion and practical management advice. The book is divided into sections: Section 1 deals with the approach to the patient with respiratory failure - including pathophysiology, investigation and diagnosis Sections 2 covers non invasive treatment modalities Sections 3 and 4 examine invasive ventilation in detail. Section 3 considers the principles of mechanical ventilation while section 4 deals with individual ventilator modes Section 5 discusses the management of the ventilated patient including sedation, monitoring, asynchrony, heart - lung interaction, hypercapnia and hypoxia, complications, weaning and extubation. It also has chapters on areas less frequently covered such as humidification, suction, tracheal tubes and principles of physiotherapy Section 6 is a comprehensive breakdown of each respiratory condition seen in ICU. This book is designed to bridge the gap between Intensive Care starter texts and all-encompassing reference textbooks. It is aimed at consultants and senior trainees in Intensive Care Medicine, senior ICU nursing staff, consultants in other specialties and allied healthcare professionals who have an interest in advanced respiratory critical care. |
| antiretroviral therapy for non-pregnant patients is: You’re Wrong, I’m Right Corey S. Scher, Anna Clebone, Sanford M. Miller, J. David Roccaforte, Levon M. Capan, 2016-11-10 This text covers the major controversies and myths in each of the major anesthesia subspecialties. You're Wrong, I'm Right is designed to be an easy and engaging evidence based read that offers the fast-paced give-and-take of a debate between two experts at the top of their game--capturing their full argument, including expressions of humor and displays of temper. Each point of contention begins with a real case, carefully selected to encapsulate the argument. One author then argues the pro side and another the con. Sometimes a single author may argue both sides. In doing so, the authors highlight the newest evidence and remind us of classic principles that have stood the test of time. At the end of the debate, readers can determine which argument they will use in their clinical practice, and may also consult a final Consensus” section that identifies the editors' and contributors' picks of the one best practice in a range of different situations. |
| antiretroviral therapy for non-pregnant patients is: Antivirals: Advances in Research and Application: 2011 Edition , 2012-01-09 Antivirals: Advances in Research and Application: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Antivirals. The editors have built Antivirals: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Antivirals in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Antivirals: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
Antiretroviral Therapy - PAHO
Jun 28, 2021 · Explore comprehensive information on antiretroviral therapy (ART) for HIV, including the latest guidelines, benefits, and PAHO's strategic initiatives. Learn about the importance of …
OPS/OMS | Organización Panamericana de la Salud - PAHO
La terapia antirretroviral (TAR) es el tratamiento de las personas infectadas con el virus de la inmunodeficiencia humana (VIH) con fármacos anti-VIH. El tratamiento consiste en una …
TRATAMIENTO ANTIRRETROVIRAL PARA
el Tratamiento Antiretroviral (TARV) y el 90% de las personas en tratamiento tengan una Carga Viral (CV) suprimida a menos de 1,000 copias/ml. El continuo de atención integral de la persona con …
Documents - PAHO/WHO | Pan American Health Organization
Jul 16, 2021 · Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Interim …
HIV/AIDS - PAHO/WHO | Pan American Health Organization
Mar 27, 2025 · Approximately 1.7 million people living with HIV were receiving antiretroviral treatment (ART) in Latin America and 240,000 in the Caribbean by the end of 2023, accounting …
Directrices unificadas sobre el uso de los antirretrovirales para el ...
Jun 21, 2016 · [Prefacio]. En estas directrices se presenta el contenido publicado anteriormente en los siguientes dos documentos: Guideline on when to start antiretroviral therapy and on pre …
Consolidated guidelines on the use of antiretroviral drugs for
Jun 21, 2016 · Recommendations for a public health approach - Second edition Overview These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, …
Updated recommendations on first-line and second-line …
Dec 21, 2018 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral …
Directrices unificadas sobre el uso de los antirretrovirales en el ...
Mar 11, 2013 · Con esta publicación la OMS presenta sus primeras directrices unificadas sobre el uso de los antirretrovirales en el tratamiento y la prevención de la infección por VIH. Las …
Concept note: Surveillance of HIV drug resistance in adults ... - PAHO
Jul 7, 2014 · HIV Drug Resistance (HIVDR) emerges when HIV replicates in the presence of antiretroviral drugs. If HIV drug resistance becomes widespread, the drugs currently used to …
Antiretroviral Therapy - PAHO
Jun 28, 2021 · Explore comprehensive information on antiretroviral therapy (ART) for HIV, including the latest guidelines, benefits, and PAHO's strategic initiatives. Learn about the …
OPS/OMS | Organización Panamericana de la Salud - PAHO
La terapia antirretroviral (TAR) es el tratamiento de las personas infectadas con el virus de la inmunodeficiencia humana (VIH) con fármacos anti-VIH. El tratamiento consiste en una …
TRATAMIENTO ANTIRRETROVIRAL PARA
el Tratamiento Antiretroviral (TARV) y el 90% de las personas en tratamiento tengan una Carga Viral (CV) suprimida a menos de 1,000 copias/ml. El continuo de atención integral de la …
Documents - PAHO/WHO | Pan American Health Organization
Jul 16, 2021 · Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Interim …
HIV/AIDS - PAHO/WHO | Pan American Health Organization
Mar 27, 2025 · Approximately 1.7 million people living with HIV were receiving antiretroviral treatment (ART) in Latin America and 240,000 in the Caribbean by the end of 2023, …
Directrices unificadas sobre el uso de los antirretrovirales para el ...
Jun 21, 2016 · [Prefacio]. En estas directrices se presenta el contenido publicado anteriormente en los siguientes dos documentos: Guideline on when to start antiretroviral therapy and on pre …
Consolidated guidelines on the use of antiretroviral drugs for
Jun 21, 2016 · Recommendations for a public health approach - Second edition Overview These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) …
Updated recommendations on first-line and second-line …
Dec 21, 2018 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral …
Directrices unificadas sobre el uso de los antirretrovirales en el ...
Mar 11, 2013 · Con esta publicación la OMS presenta sus primeras directrices unificadas sobre el uso de los antirretrovirales en el tratamiento y la prevención de la infección por VIH. Las …
Concept note: Surveillance of HIV drug resistance in adults
Jul 7, 2014 · HIV Drug Resistance (HIVDR) emerges when HIV replicates in the presence of antiretroviral drugs. If HIV drug resistance becomes widespread, the drugs currently used to …
